Retailers and High Value Network Individuals (HNIs) would be in the wrong if Gland Pharma’s initial public offering (IPO) promoted by Fosun in China was lost. Shares of the Hyderabad-based company have gained 40 percent over its IPO price of 1,500 rupees. On Monday, the shares rose 15 percent to …
Read More »Why Retail and HNI Investors May Be Regretting Losing Gland Pharma’s IPO
